Product Overview: Silagra-100 Cipla
Silagra-100 Cipla is a sildenafil citrate formulation manufactured by Cipla for scientific research applications. This phosphodiesterase type 5 (PDE5) inhibitor compound serves as a valuable reference material for researchers investigating cyclic guanosine monophosphate (cGMP) pathway modulation and nitric oxide signalling mechanisms. Our UK-based laboratory at Stroid UK Shop supplies this research-grade compound to qualified institutions examining cardiovascular and cellular physiology models.
Research Applications and Mechanism
In laboratory studies, sildenafil citrate demonstrates selective inhibition of PDE5 enzymes, preventing the hydrolysis of cGMP in cell culture systems. This mechanism enables researchers to investigate smooth muscle relaxation pathways, endothelial function models, and vascular biology research protocols. Scientists studying cardiovascular research frequently examine this compound alongside other laboratory materials available in our sildenafil citrate research section. The compound’s well-characterized pharmacological profile makes it suitable for comparative studies with experimental selective androgen receptor modulators and peptide compounds in multi-target research protocols examining cellular signalling pathways.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | Sildenafil Citrate |
| Manufacturer | Cipla |
| Molecular Formula | C₂₂H₃₀N₆O₄S·C₆H₈O₇ |
| CAS Number | 171599-83-0 (citrate salt) |
| Molecular Weight | 666.7 g/mol |
| Storage Conditions | Room temperature, dry environment |
Research Compliance Information
This sildenafil citrate preparation is supplied exclusively for in-vitro research applications and laboratory analytical procedures. Silagra-100 Cipla is intended solely for qualified researchers conducting studies in controlled laboratory environments examining PDE5 inhibition mechanisms and related cellular pathways. This product is not approved for human consumption, clinical use, or any therapeutic applications. Researchers must ensure compliance with institutional safety protocols and maintain appropriate documentation for laboratory chemical inventory management systems.

